71 papers found
Refreshing results…
Downregulation of PUMA underlies resistance to FGFR1 inhibitors in the stem cell leukemia/lymphoma syndrome
IL-21 from high-affinity CD4 T cells drives differentiation of brain-resident CD8 T cells during persistent viral infection
Distinct signaling programs associated with progression of FGFR1 driven leukemia in a mouse model of stem cell leukemia lymphoma syndrome
Critical individual roles of the BCR and FGFR1 kinase domains in BCR‐FGFR1‐driven stem cell leukemia/lymphoma syndrome
CD40L inhibits cell growth of THP-1 cells by suppressing the PI3K/Akt pathway [Corrigendum]
CD40L inhibits cell growth of THP-1 cells by suppressing the PI3K/Akt pathway
Evidence of nematic order and nodal superconducting gap along [110] direction in RbFe2As2
Loss of the BCR-FGFR1 GEF Domain Suppresses RHOA Activation and Enhances B-Lymphomagenesis in Mice
Multifactorial Origin of Exertional Rhabdomyolysis, Recurrent Hematuria, and Episodic Pain in a Service Member with Sickle Cell Trait
Pathogenic and rare deleterious variants in multiple genes suggest oligogenic inheritance in recurrent exertional rhabdomyolysis
FGFR1 fusion kinase regulation of MYC expression drives development of stem cell leukemia/lymphoma syndrome
The miR-17/92 cluster is involved in the molecular etiology of the SCLL syndrome driven by the BCR-FGFR1 chimeric kinase
SALL1 expression in acute myeloid leukemia
Mutation in the FGFR1 tyrosine kinase domain or inactivation of PTEN is associated with acquired resistance to FGFR inhibitors in FGFR1-driven leukemia/lymphomas: Mechanisms of resistance to FGFR inhibitors in leukemia/lymphoma cells
Superconductivity across Lifshitz transition and anomalous insulating state in surface K–dosed (Li 0.8 Fe 0.2 OH)FeSe
A combination of valproic acid sodium salt, CHIR99021, E-616452, tranylcypromine, and 3-Deazaneplanocin A causes stem cell-like characteristics in cancer cells
Tracing anti-cancer and cancer-promoting actions of all-trans retinoic acid in breast cancer to a RARα epigenetic mechanism of mammary epithelial cell fate
Targeting FGFR1 to suppress leukemogenesis in syndromic and de novo AML in murine models
Development of ZMYM2-FGFR1 driven AML in human CD34+ cells in immunocompromised mice: Model of ZMYM2-FGFR1 driven AML
12885 2016 2105 Moesm1 Esm
Missing publications? Read more about our data sources.